It has been a mixed year for Serina Therapeutics, Inc. insiders: $78,000 bought by four people and $501,000 sold by one, so more selling than buying overall.
The largest purchase came from Marshall Richard Peter (Director), about $20,000.
On the institutional side, 27 funds reported holding SER at the end of Q2 2026, and more funds bought than sold. Zooming out by quarter: 2 quarters in a row of net buying by insiders. Insiders bought in 2 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Jul 9, 2026 | Brannan Stephen K. | Director | Buy | 1,000 | $2.03 | $2K | SEC |
| Jun 22, 2026 | Venkatesan Jay | Director | Buy | 589 | $1.78 | $1K | SEC |
| Jun 15, 2026 | WILSON KAREN J | Director | Buy | 5,100 | $1.75 | $9K | SEC |
| Jun 15, 2026 | WILSON KAREN J | Director | Buy | 5,000 | $1.77 | $9K | SEC |
| May 26, 2026 | WILSON KAREN J | Director | Buy | 10,000 | $1.77 | $18K | SEC |
| May 26, 2026 | WILSON KAREN J | Director | Buy | 10,000 | $1.93 | $19K | SEC |
| May 22, 2026 | Marshall Richard Peter | Director | Buy | 12,183 | $1.65 | $20K | SEC |
| Mar 24, 2026 | Moreadith Randall | Executive Officer | Sell | 6,500 | $2.86 | $19K | SEC |
| Mar 20, 2026 | Moreadith Randall | Executive Officer | Sell | 39,000 | $2.50 | $98K | SEC |
| Feb 3, 2026 | Moreadith Randall | Executive Officer | Sell | 6,500 | $3.03 | $20K | SEC |
| Jan 29, 2026 | Moreadith Randall | Executive Officer | Sell | 6,500 | $3.57 | $23K | SEC |
| Jan 23, 2026 | Moreadith Randall | Executive Officer | Sell | 2,500 | $2.95 | $7K | SEC |
| Jan 21, 2026 | Moreadith Randall | Executive Officer | Sell | 2,000 | $3.07 | $6K | SEC |
| Jan 21, 2026 | Moreadith Randall | Executive Officer | Sell | 2,000 | $3.00 | $6K | SEC |
| Jan 14, 2026 | Moreadith Randall | Executive Officer | Sell | 1,084 | $2.50 | $3K | SEC |
In the last 12 months Serina Therapeutics, Inc. insiders made open-market purchases worth about $78,000 and sales worth about $501,000. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in SER was filed on 2026-07-09.
27 investment managers reported holding SER in SEC Form 13F filings for Q2 2026.
No congressional trades in SER were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).